Lewei Pharmaceutical
PrivateLast Round
Series C
Dec 27, 2022
Total Funding Raised
$141.58M
Company Overview
Laviana is a pharmaceutical outsourcing company that specializes in transforming innovative medicine from laboratory to industrial processes, optimizing market-based drug research, and utilizing advanced analytical methods for drug development and testing.
Sector
Healthcare & Life Sciences
Verticals
Pharma Supply Chain, Clinical Trials, Drug Discovery, Biotechnology
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Lewei Pharmaceutical Comparables
Compare Lewei Pharmaceutical with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Bellen Chemistry | 88% | |
| Chongqing Sintaho Pharmaceutical Co., Ltd. | 82% | |
| Sterling Pharma Solutions | 82% | |
Lewei Pharmaceutical Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Dec 27, 2022 | ||||
| Series C | Oct 13, 2021 | ||||
| Series B | Aug 26, 2019 | ||||
| Series B | Jan 2, 2018 | ||||
| Series A | Mar 1, 2014 |
Lewei Pharmaceutical Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| ABC Capital | Series B |
| V-Capital | Series B |
| LYFE Capital | Series B |
| Yingke PE | Series C |
| Huayi Capital | Series B |
| HRVC Capital | Series C |
| HY Capital | Series C |
Lewei Pharmaceutical Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |